Based on the data available at this time, there is no indication of a device malfunction causing or contributing to the inappropriate treatment.Inappropriate defibrillations are an anticipated risk associated with the use of the lifevest.Patients are instructed through alarms, voice messages, ifu, and training to press the response buttons to prevent an inappropriate defibrillation.The current commercial inappropriate defibrillation rate is consistent with the observed rate during the pivotal clinical trial (b)(6) (0.69% per patient-month with 90% confidence).A summary of the safety and effectiveness data (ssed), including the inappropriate defibrillation safety objective supporting fda's approval of the lifevest, can be found at http://www.Accessdata.Fda.Gov/cdrh_docs/pdf/p010030b.Pdf.The lifevest detection algorithm complies with iec 60601-2-4 performance requirements for sensitivity and specificity.
|
The patient was inappropriately treated 7 times by the lifevest.The patient was reportedly conscious at the time of the event.Motion artifact contributed to the false detections.The response buttons were not pressed during the event.The nurse reported the patient is confused and has possible cognitive issues.The patient did not press the rb¿s as the monitor was not near the patient.No injury was reported from the treatment.The patient was in the hospital prior to the event, during the event, and remained there following the event.It is unknown if the patient continued to use the lifevest.No deficiencies were alleged against the device.
|